CGL Polyclonal Antibody

This gene encodes a cytoplasmic enzyme in the trans-sulfuration pathway that converts cystathione derived from methionine into cysteine. Glutathione synthesis in the liver is dependent upon the availability of cysteine. Mutations in this gene cause cystathioninuria. Alternative splicing of this gene results in three transcript variants encoding different isoforms.

The CGL Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of CGL (Chronic Granulomatous Disease) in various biological samples. This antibody is produced using state-of-the-art technology and has been extensively validated to ensure its superior performance.

With its exceptional sensitivity and specificity, the CGL Polyclonal Antibody enables accurate identification and quantification of CGL in a wide range of applications, including immunohistochemistry, immunofluorescence, and Western blotting. It exhibits minimal cross-reactivity with other related antigens, ensuring precise and reliable results.

The CGL Polyclonal Antibody is supplied as a ready-to-use solution, eliminating the need for time-consuming and complex preparation steps. Its high affinity and robust binding capacity ensure optimal signal-to-noise ratios, enabling clear and distinct visualization of CGL in samples.

This antibody is manufactured under strict quality control standards, guaranteeing batch-to-batch consistency and reproducibility. It is provided in a convenient size and format, allowing for easy handling and storage.

In summary, the CGL Polyclonal Antibody is a valuable tool for researchers and clinicians involved in the study and diagnosis of Chronic Granulomatous Disease. Its exceptional performance, reliability, and ease of use make it an indispensable asset in the field of immunology and biomedical research.